An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
Recruiting now
Conditions studied: Total Hip Replacement, Total Knee Replacement
In brief
This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone total joint replacement as a post-op communication tool. Data will be collected on how effectively the product guides patients through their recovery, identifying potential complications, and providing appropriate recommendations based on structured question pairs.
Key facts
- Study ID
- NCT07120191
- Run by
- Concentra AI, inc
- People needed
- 200
- Starts
- 2025-05-01
- Expected to finish
- 2025-11-30
- Last updated by the study team
- 2025-08-15
Who can join
Age: 22 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Orthopedic patients scheduled for elective joint arthroplasty (single or double knee, or single or double hip replacement surgery).
- Age 22-80 years. Owns a smart phone. Speaks and understands written and spoken English. Ability to give written informed consent.
You may not qualify if…
- Known diagnosis of a psychiatric disorder. Known opioid dependence in the Investigator's opinion that may complicate participation.
- Participation in another clinical trial investigating a drug, medical device, or a medical procedure in the 30 days preceding trial inclusion and throughout the duration of the trial.
- Any condition that in the Investigator's opinion may complicate or preclude the subject from participating in this trial, such as physical impairment or noncooperation
Where it is running
- Kansas Joint and Spine — Wichita, Kansas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.